Emral, R. Et Al. 2021. Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study. DIABETES THERAPY , vol.12, no.11 , 2857-2870.

Emral, R., Haymana, C., Demirci, I., Tasci, I., Sahin, M., Cakal, E., ... Ata, N.(2021). Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study. DIABETES THERAPY , vol.12, no.11, 2857-2870.

Emral, Rifat Et Al. "Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study," DIABETES THERAPY , vol.12, no.11, 2857-2870, 2021

Emral, Rifat Et Al. "Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study." DIABETES THERAPY , vol.12, no.11, pp.2857-2870, 2021

Emral, R. Et Al. (2021) . "Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study." DIABETES THERAPY , vol.12, no.11, pp.2857-2870.

@article{article, author={Rifat Emral Et Al. }, title={Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study}, journal={DIABETES THERAPY}, year=2021, pages={2857-2870} }